Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00208_DB00726_nanopub.RA7X2V_ZqgQgZRUfMm9wOJlLZB8Wrr_l14VZPgHm1bz_s#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00208_DB00726 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00208_DB00726 label "DDI between Ticlopidine and Trimipramine - The strong CYP2C19 inhibitor, ticlopidine, may decrease the metabolism and clearance of trimipramine, a CYP2C19 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of trimipramine if ticlopidine is initiated, discontinued or dose changed. [drugbank_resource:DB00208_DB00726]" assertion.
- drugbank_resource:DB00208_DB00726 identifier "drugbank_resource:DB00208_DB00726" assertion.
- drugbank_resource:DB00208_DB00726 title "DDI between Ticlopidine and Trimipramine - The strong CYP2C19 inhibitor, ticlopidine, may decrease the metabolism and clearance of trimipramine, a CYP2C19 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of trimipramine if ticlopidine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00208_DB00726 assertion.
- drugbank:DB00208 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00208_DB00726 assertion.